Use of low-dose oral contraceptives and stroke in young women

Annals of Internal Medicine

Volumn 127, Issue 8 I, 1997, Pages 596-603

  Schwartz, Stephen M ^a,b   Siscovick, David S ^a,b   Longstreth Jr , W T ^a,c   Psaty, Bruce M ^a,b   Beverly, R Kevin ^a   Raghunathan, T E ^a,d   Lin, Danyu ^a,b   Koepsell, Thomas D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETYNODIOL DIACETATE; LEVONORGESTREL; NORETHISTERONE; NORETHISTERONE ACETATE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0030772383     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-8_part_1-199710150-00003     Document Type: Article

References (23)

1. Inman WH, Vessey MP. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J. 1968;2:193-9.
2. Oral contraceptives and venous thrornboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. Lancet. 1973;1:1399-404.
3. Mortality among oral contraceptive users. Royal College of General Practitioners' Oral Contraceptive Study. Lancet. 1977;2:727-31.
4. Mann JI, Inman WH. Oral contraceptives and death from myocardial infarction. Br Med J. 1975;2:245-8.
5. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ. 1993;306:956-63.
6. Thorogood M, Mann M, Murphy M, Vessey M. Fatal stroke and use of oral contraceptives: findings from a case-control study. Am J Epidemiol. 1992; 136:35-45.
7. Longstreth WT, Nelson LM, Koepsell TD, van Belle G. Subarachnoid hemorrage and hormonal factors in women. A population-based case-control study. Ann Intern Med. 1994;121:168-73.
8. Meade TW, Greenberg G, Thompson SG. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br Med J. 1980;280:1157-61.
9. Kay CR. Progestogens and arterial disease - evidence from the Royal College of General Practitioners' study. Am J Obstet Gynecol. 1982;142(6 pt 2):762-5.
10. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med. 1996;335:8-15.
11. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol. 1984;120:825-33.
12. Nelson LM, Longstreth WT Jr, Koepsell TO, van Belle G. Proxy respondents in epidemiologic research. Epidemiol Rev. 1990;12:71-86.
13. Thompson WD Jr. Statistical analysis of case-control studies. Epidemiol Rev. 1994;16:33-50.
14. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1996;348:505-10.
15. Ischemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1996;348:498-505.
16. Meade TW, Haines AP, North WR, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 μg or 30 μg oestrogen. Lancet. 1977,2:948-51.
17. Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception. 1995;52:143-9.
18. Phillips A, Hahn DW, Klimek S, McGuire JL. A comparison of the potencies and activities of progestogens used in contraceptives. Contraception. 1987;36:181-92.
19. Brincat M, Moniz CF, Studd JW, Darby AJ, Magos A, Cooper D. Sex homones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed). 1983;287:1337-8.
20. Bolognia JL, Braverman IM, Rousseau ME, Sarrel PM. Skin changes in menopause. Maturitas. 1989;11:295-304.
21. Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 1991;338:839-42.
22. Realini JP, Goldzieher JW. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies. Am J Obstet Gynecol. 1985;152(6 pt 2):729-98.
23. Vessey MP. Benefits and risks of combined oral contraceptives. Methods Inf Med. 1993;32:222-4.